Antiviral activity assessment of remdesivir against 10 current and former SARS-CoV-2 variant clinical isolates
![](./upload/news/image_1644951458_63943846.jpg)
A new study published demonstrated the in vitro potencies of RDV and GS-441524 through PRA, and nucleoprotein ELISA against SARS-CoV-2 and other VOC/VOIs isolates with specific substitutions in Nsp12.